Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Mar 1;183(3):829–836. doi: 10.1084/jem.183.3.829

Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy

PMCID: PMC2192353  PMID: 8642287

Abstract

Evaluation of human histocompatibility leukocyte antigen (HLA) class II genes in 54 cases of tuberculoid leprosy (TL) and 44 controls has shown a positive association with HLA-DRB1 alleles that contain Arg13 or Arg70-Arg71. Among TL patients, 87% carry specific alleles of DRB1 Arg13 or Arg70-Arg71 as compared to 43% among controls (p = 5 x 10(-6)) conferring a relative risk of 8.8. Thus, susceptibility to TL involves three critical amino acid positions of the beta chain, the side chains of which, when modeled on the DR1 crystal structure, line a pocket (pocket 4) accommodating the side chain of a bound peptide. This study suggests that disease susceptibility may be determined by the independent contribution of polymorphic residues participating in the formation of a functional arrangement (i.e., pocket) within the binding cleft of an HLA molecule.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjorkman P. J., Saper M. A., Samraoui B., Bennett W. S., Strominger J. L., Wiley D. C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987 Oct 8;329(6139):506–512. doi: 10.1038/329506a0. [DOI] [PubMed] [Google Scholar]
  2. Brown J. H., Jardetzky T. S., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L., Wiley D. C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993 Jul 1;364(6432):33–39. doi: 10.1038/364033a0. [DOI] [PubMed] [Google Scholar]
  3. Chicz R. M., Urban R. G., Lane W. S., Gorga J. C., Stern L. J., Vignali D. A., Strominger J. L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature. 1992 Aug 27;358(6389):764–768. doi: 10.1038/358764a0. [DOI] [PubMed] [Google Scholar]
  4. Cohn Z. A., Kaplan G. Hansen's disease, cell-mediated immunity, and recombinant lymphokines. J Infect Dis. 1991 Jun;163(6):1195–1200. doi: 10.1093/infdis/163.6.1195. [DOI] [PubMed] [Google Scholar]
  5. Falk K., Rötzschke O., Stevanović S., Jung G., Rammensee H. G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 1991 May 23;351(6324):290–296. doi: 10.1038/351290a0. [DOI] [PubMed] [Google Scholar]
  6. Fu X. T., Bono C. P., Woulfe S. L., Swearingen C., Summers N. L., Sinigaglia F., Sette A., Schwartz B. D., Karr R. W. Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J Exp Med. 1995 Mar 1;181(3):915–926. doi: 10.1084/jem.181.3.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Geluk A., Van Meijgaarden K. E., Janson A. A., Drijfhout J. W., Meloen R. H., De Vries R. R., Ottenhoff T. H. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. J Immunol. 1992 Nov 1;149(9):2864–2871. [PubMed] [Google Scholar]
  8. Germain R. N., Margulies D. H. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol. 1993;11:403–450. doi: 10.1146/annurev.iy.11.040193.002155. [DOI] [PubMed] [Google Scholar]
  9. Hammer J., Gallazzi F., Bono E., Karr R. W., Guenot J., Valsasnini P., Nagy Z. A., Sinigaglia F. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med. 1995 May 1;181(5):1847–1855. doi: 10.1084/jem.181.5.1847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hammer J., Takacs B., Sinigaglia F. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med. 1992 Oct 1;176(4):1007–1013. doi: 10.1084/jem.176.4.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hastings R. C., Gillis T. P., Krahenbuhl J. L., Franzblau S. G. Leprosy. Clin Microbiol Rev. 1988 Jul;1(3):330–348. doi: 10.1128/cmr.1.3.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Izumi S., Sugiyama K., Matsumoto Y., Ohkawa S. Analysis of the immunogenetic background of Japanese leprosy patients by the HLA system. Vox Sang. 1982;42(5):243–247. doi: 10.1111/j.1423-0410.1982.tb00751.x. [DOI] [PubMed] [Google Scholar]
  13. Jorgensen J. L., Reay P. A., Ehrich E. W., Davis M. M. Molecular components of T-cell recognition. Annu Rev Immunol. 1992;10:835–873. doi: 10.1146/annurev.iy.10.040192.004155. [DOI] [PubMed] [Google Scholar]
  14. Karr R. W., Panina-Bordignon P., Yu W. Y., Lanzavecchia A. Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions. J Immunol. 1991 Jun 15;146(12):4242–4247. [PubMed] [Google Scholar]
  15. Kim S. J., Choi I. H., Dahlberg S., Nisperos B., Kim J. D., Hansen J. A. HLA and leprosy in Koreans. Tissue Antigens. 1987 Mar;29(3):146–153. doi: 10.1111/j.1399-0039.1987.tb01567.x. [DOI] [PubMed] [Google Scholar]
  16. Malcherek G., Falk K., Rötzschke O., Rammensee H. G., Stevanović S., Gnau V., Jung G., Melms A. Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis. Int Immunol. 1993 Oct;5(10):1229–1237. doi: 10.1093/intimm/5.10.1229. [DOI] [PubMed] [Google Scholar]
  17. Mehra N. K., Bouwens A. G., Naipal A., Rajalingam R., Grubic Z., Taneja V., Tilanus M. G., Giphart M. J. Asian Indian HLA-DR2-, DR4-, and DR52-related DR-DQ genotypes analyzed by polymerase chain reaction based nonradioactive oligonucleotide typing. Unique haplotypes and a novel DR4 subtype. Hum Immunol. 1994 Mar;39(3):202–210. doi: 10.1016/0198-8859(94)90261-5. [DOI] [PubMed] [Google Scholar]
  18. Mehra N. K. Role of HLA linked factors in governing susceptibility to leprosy and tuberculosis. Trop Med Parasitol. 1990 Sep;41(3):352–354. [PubMed] [Google Scholar]
  19. Mehra N. K., Verduijn W., Taneja V., Drabbels J., Singh S. P., Giphart M. J. Analysis of HLA-DR2-associated polymorphisms by oligonucleotide hybridization in an Asian Indian population. Hum Immunol. 1991 Dec;32(4):246–253. doi: 10.1016/0198-8859(91)90087-p. [DOI] [PubMed] [Google Scholar]
  20. Merryman P. F., Crapper R. M., Lee S., Gregersen P. K., Winchester R. J. Class II major histocompatibility complex gene sequences in rheumatoid arthritis. The third diversity regions of both DR beta 1 genes in two DR1, DRw10-positive individuals specify the same inferred amino acid sequence as the DR beta 1 and DR beta 2 genes of a DR4 (Dw14) haplotype. Arthritis Rheum. 1989 Mar;32(3):251–258. doi: 10.1002/anr.1780320304. [DOI] [PubMed] [Google Scholar]
  21. Miyanaga K., Juji T., Maeda H., Nakajima S., Kobayashi S. Tuberculoid leprosy and HLA in Japanese. Tissue Antigens. 1981 Nov;18(5):331–334. doi: 10.1111/j.1399-0039.1981.tb01400.x. [DOI] [PubMed] [Google Scholar]
  22. Nathenson S. G., Geliebter J., Pfaffenbach G. M., Zeff R. A. Murine major histocompatibility complex class-I mutants: molecular analysis and structure-function implications. Annu Rev Immunol. 1986;4:471–502. doi: 10.1146/annurev.iy.04.040186.002351. [DOI] [PubMed] [Google Scholar]
  23. Nepom G. T., Byers P., Seyfried C., Healey L. A., Wilske K. R., Stage D., Nepom B. S. HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum. 1989 Jan;32(1):15–21. doi: 10.1002/anr.1780320104. [DOI] [PubMed] [Google Scholar]
  24. Nicholls A., Sharp K. A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 1991;11(4):281–296. doi: 10.1002/prot.340110407. [DOI] [PubMed] [Google Scholar]
  25. Olson R. R., De Magistris M. T., Di Tommaso A., Karr R. W. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide. J Immunol. 1992 May 1;148(9):2703–2708. [PubMed] [Google Scholar]
  26. Ottenhoff T. H., Gonzalez N. M., de Vries R. R., Convit J., van Rood J. J. Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population. Tissue Antigens. 1984 Jul;24(1):25–29. doi: 10.1111/j.1399-0039.1984.tb00393.x. [DOI] [PubMed] [Google Scholar]
  27. Rani R., Fernandez-Vina M. A., Zaheer S. A., Beena K. R., Stastny P. Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India. Tissue Antigens. 1993 Sep;42(3):133–137. doi: 10.1111/j.1399-0039.1993.tb02179.x. [DOI] [PubMed] [Google Scholar]
  28. Rani R., Zaheer S. A., Mukherjee R. Do human leukocyte antigens have a role to play in differential manifestation of multibacillary leprosy: a study on multibacillary leprosy patients from north India. Tissue Antigens. 1992 Sep;40(3):124–127. doi: 10.1111/j.1399-0039.1992.tb02103.x. [DOI] [PubMed] [Google Scholar]
  29. Rea T. H., Terasaki P. I. HLA-DR antigens in tuberculoid and lepromatous leprosy. Lepr Rev. 1980 Jun;51(2):117–123. doi: 10.5935/0305-7518.19800010. [DOI] [PubMed] [Google Scholar]
  30. Richeldi L., Sorrentino R., Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science. 1993 Oct 8;262(5131):242–244. doi: 10.1126/science.8105536. [DOI] [PubMed] [Google Scholar]
  31. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  32. Rudensky AYu, Preston-Hurlburt P., al-Ramadi B. K., Rothbard J., Janeway C. A., Jr Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature. 1992 Oct 1;359(6394):429–431. doi: 10.1038/359429a0. [DOI] [PubMed] [Google Scholar]
  33. Schauf V., Ryan S., Scollard D., Jonasson O., Brown A., Nelson K., Smith T., Vithayasai V. Leprosy associated with HLA-DR2 and DQw1 in the population of northern Thailand. Tissue Antigens. 1985 Oct;26(4):243–247. doi: 10.1111/j.1399-0039.1985.tb00966.x. [DOI] [PubMed] [Google Scholar]
  34. Sette A., Sidney J., Oseroff C., del Guercio M. F., Southwood S., Arrhenius T., Powell M. F., Colón S. M., Gaeta F. C., Grey H. M. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J Immunol. 1993 Sep 15;151(6):3163–3170. [PubMed] [Google Scholar]
  35. Stern L. J., Brown J. H., Jardetzky T. S., Gorga J. C., Urban R. G., Strominger J. L., Wiley D. C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994 Mar 17;368(6468):215–221. doi: 10.1038/368215a0. [DOI] [PubMed] [Google Scholar]
  36. Todd J. R., West B. C., McDonald J. C. Human leukocyte antigen and leprosy: study in northern Louisiana and review. Rev Infect Dis. 1990 Jan-Feb;12(1):63–74. doi: 10.1093/clinids/12.1.63. [DOI] [PubMed] [Google Scholar]
  37. de Vries R. R. 1991 Mack Forster Award Lecture. HLA and disease: from epidemiology to immunotherapy. Eur J Clin Invest. 1992 Jan;22(1):1–8. doi: 10.1111/j.1365-2362.1992.tb01928.x. [DOI] [PubMed] [Google Scholar]
  38. de Vries R. R., Mehra N. K., Vaidya M. C., Gupte M. D., Meera Khan P., Van Rood J. J. HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types. Tissue Antigens. 1980 Oct;16(4):294–304. doi: 10.1111/j.1399-0039.1980.tb00309.x. [DOI] [PubMed] [Google Scholar]
  39. van Eden W., Gonzalez N. M., de Vries R. R., Convit J., van Rood J. J. HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis. 1985 Jan;151(1):9–14. doi: 10.1093/infdis/151.1.9. [DOI] [PubMed] [Google Scholar]
  40. van Eden W., de Vries R. R., D'Amaro J., Schreuder I., Leiker D. L., van Rood J. J. HLA-DR-associated genetic control of the type of leprosy in a population from surinam. Hum Immunol. 1982 Jul;4(4):343–350. doi: 10.1016/0198-8859(82)90007-6. [DOI] [PubMed] [Google Scholar]
  41. van Eden W., de Vries R. R., Mehra N. K., Vaidya M. C., D'Amaro J., van Rood J. J. HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker. J Infect Dis. 1980 Jun;141(6):693–701. doi: 10.1093/infdis/141.6.693. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES